Criminal Code Regulations 2019 (Cth)
Criminal Code Regulations 2019
made under the
Criminal Code Act 1995
Compilation No. 2
Compilation date: 21 December 2021
Includes amendments up to: F2021L01842
Registered: 22 December 2021
About this compilation
This compilation
This is a compilation of the Criminal Code Regulations 2019 that shows the text of the law as amended and in force on 21 December 2021 (the compilation date).
The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.
Uncommenced amendments
The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register ( The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.
Application, saving and transitional provisions for provisions and amendments
If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.
Editorial changes
For more information about any editorial changes made in this compilation, see the endnotes.
Modifications
If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.
Self‑repealing provisions
If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.
Contents
Part 1—Preliminary 1
1............ Name............................................................................................................................. 1
3............ Authority....................................................................................................................... 1
4............ Definitions..................................................................................................................... 1
Part 2—The security of the Commonwealth 2
Division 1—Control orders 2
5............ Legal representation for young people........................................................................... 2
6............ Court may request legal aid commission to arrange representation................................ 2
7............ AFP to inform relevant persons of request and contact details...................................... 2
Division 2—Preventative detention orders 4
8............ Corresponding State preventative detention laws.......................................................... 4
Division 3—Continuing detention orders 5
9............ Terrorist offender unable to engage legal representative in continuing detention order proceedings—matters court may take into account in determining whether circumstances beyond offender’s control...... 5
10.......... Sharing information—prescribed persons..................................................................... 5
Part 3—Dangers to the community 7
Division 1—Serious drugs and precursors 7
11.......... Controlled drugs............................................................................................................ 7
12.......... Controlled plants........................................................................................................... 7
13.......... Controlled precursors.................................................................................................... 7
14.......... Border controlled drugs................................................................................................. 9
15.......... Border controlled plants................................................................................................ 9
16.......... Border controlled precursors......................................................................................... 9
Division 2—Psychoactive substances 11
17.......... Importing psychoactive substances............................................................................. 11
18.......... Importing substances represented to be serious drug alternatives................................ 11
19.......... Conditions for importing certain substances................................................................ 11
Division 3—Cross‑border firearms trafficking 13
20.......... Firearm law................................................................................................................. 13
Part 4—National infrastructure 14
21.......... Dangerous or harmful substances and things that must not be carried by post............ 14
Part 5—Application, saving and transitional provisions 15
Division 1—Provisions for this instrument as originally made 15
22.......... Things done under the Criminal Code Regulations 2002............................................ 15
23.......... Conduct, event, circumstances occurring before commencement................................ 15
Schedule 1—Controlled drugs 16
1............ Controlled drugs and quantities................................................................................... 16
Schedule 2—Border controlled drugs 24
1............ Border controlled drugs and quantities........................................................................ 24
Endnotes31
Endnote 1—About the endnotes 31
Endnote 2—Abbreviation key 32
Endnote 3—Legislation history 33
Endnote 4—Amendment history 34
Part 1—Preliminary
1 Name
This instrument is the Criminal Code Regulations 2019.
3 Authority
This instrument is made under the Criminal Code Act 1995.
4 Definitions
In this instrument:
AFP member has the same meaning as in Part 5.3 of the Code.
authorised person means a person who is an authorised person for the purposes of regulation 5 of the Customs (Prohibited Imports) Regulations 1956.
chief executive officer of a legal aid commission of a State or Territory means the person holding, or performing the duties of, the following position:
(a) for New South Wales, Victoria, Queensland and the Australian Capital Territory—Chief Executive Officer of the legal aid commission of that State or Territory;
(b) for Western Australia—Director of Legal Aid under the Legal Aid Commission Act 1976 (WA);
(c) for South Australia—Director of Legal Services under the Legal Services Commission Act 1977 (SA);
(d) for Tasmania—Director of the Commission under the Legal Aid Commission Act 1990 (Tas.);
(e) for the Northern Territory—Director of Legal Aid under the Legal Aid Act1990 (NT).
Code means the Criminal Code.
control order has the same meaning as in Part 5.3 of the Code.
Health Secretary means the Secretary of the Department administered by the Minister administering the Therapeutic Goods Act 1989.
issuing court has the same meaning as in Part 5.3 of the Code.
lawyer has the same meaning as in Part 5.3 of the Code.
legal aid commission means an authority established by or under a law of a State or Territory for the purpose of providing legal assistance.
young person means a person who is at least 14 but under 18.
Part 2—The security of the Commonwealth
Division 1—Control orders
5 Legal representation for young people
For the purposes of subsection 104.28(6) of the Code, this Division provides in relation to the appointing of a lawyer to act for a young person in relation to proceedings relating to a control order.
6 Court may request legal aid commission to arrange representation
An issuing court may request a legal aid commission to arrange the legal representation of a young person in proceedings relating to a control order.
7 AFP to inform relevant persons of request and contact details
(1) This section applies if an issuing court requests a legal aid commission under section 6 to arrange the legal representation of a young person in proceedings relating to a control order.
Informing the legal aid commission
(2) An AFP member, or a legal representative of the Australian Federal Police, must:
(a) in writing, inform the chief executive officer of the legal aid commission of the request; and
(b) give the legal aid commission the following information that the AFP member or legal representative has:
(i) the young person’s name;
(ii) the young person’s residential address;
(iii) the young person’s contact details, including a telephone number and an email address;
(iv) the young person’s date of birth;
(v) the name, residential address and contact details of at least one parent or guardian of the young person;
(vi) if the young person requires assistance with communication—information about the assistance required.
Note: For subparagraph (b)(vi), a young person may need assistance with communication because, for example, the person is deaf or hearing impaired, is unable to read, has a mental impairment, or requires an interpreter.
Informing the young person
(3) An AFP member, or a legal representative of the Australian Federal Police, must:
(a) inform the young person of the request; and
(b) give the young person sufficient information about the legal aid commission to enable the young person to contact and, if necessary, attend the legal aid commission, including the following information that the AFP member or legal representative has:
(i) the name of the legal aid commission;
(ii) the legal aid commission’s business address (not being a post box);
(iii) the legal aid commission’s contact details, including a telephone number and an email address;
(iv) any other information about the legal aid commission provided by the issuing court; and
(c) ensure that the young person understands the information provided to them under paragraphs (a) and (b) (taking into account the person’s age, language skills, mental capacity and any other relevant factor).
(4) Subsection (3) does not apply if the actions of the young person make it impracticable for the AFP member or legal representative to comply with that subsection.
Informing a parent or guardian of the young person
(5) An AFP member, or a legal representative of the Australian Federal Police, must take reasonable steps to:
(a) inform at least one parent or guardian of the young person of the request; and
(b) give the parent or guardian the information about the legal aid commission that is required to be provided to the young person under paragraph (3)(b).
Timing
(6) An AFP member or legal representative of the Australian Federal Police complying with subsection (2), (3) or (5) must do so as soon as practicable after the issuing court makes the request and at least 48 hours before the next day when the court will conduct proceedings relating to the control order.
Division 2—Preventative detention orders
8 Corresponding State preventative detention laws
For the purposes of the definition of corresponding State preventative detention law in subsection 100.1(1) of the Code, the following are declared to correspond to Division 105 of the Code:
(a) Part 2A of the Terrorism (Police Powers) Act 2002 (NSW);
(b) Part 2A of the Terrorism (Community Protection) Act 2003 (Vic.);
(c) the Terrorism (Preventative Detention) Act 2005 (Qld);
(d) the Terrorism (Preventative Detention) Act 2006 (WA);
(e) the Terrorism (Preventative Detention) Act 2005 (SA);
(f) the Terrorism (Preventative Detention) Act 2005 (Tas.);
(g) Part 2 of the Terrorism (Extraordinary Temporary Powers) Act 2006 (ACT);
(h) Part 2B of the Terrorism (Emergency Powers) Act 2003 (NT).
Division 3—Continuing detention orders
9 Terrorist offender unable to engage legal representative in continuing detention order proceedings—matters court may take into account in determining whether circumstances beyond offender’s control
For the purposes of paragraph 105A.15A(3)(a) of the Code, the following matters are prescribed as matters that a Supreme Court of a State or Territory may take into account in determining whether circumstances are beyond an offender’s control in relation to a continuing detention order proceeding:
(a) the offender’s financial circumstances;
(b) whether the offender has engaged in unreasonable conduct during the proceeding that has contributed to the offender’s inability to afford any or all of the costs and expenses of obtaining legal representation for the proceeding;
(c) whether the offender has made any efforts to obtain legal aid or legal assistance, and the outcomes of any such efforts;
(d) any other matter that the Court considers relevant.
10 Sharing information—prescribed persons
For the purposes of subsections 105A.19(1) and (3) of the Code, the following persons are prescribed:
(a) a senior executive AFP employee or an AFP employee who is acting as, or performing the duties of, a senior executive AFP employee (all within the meaning of the Australian Federal Police Act 1979);
(b) a member of the police force or police service of a State or Territory;
(c) an officer or employee of a State or Territory, or of an authority of a State or Territory, whose duties relate to corrective services (including prison medical, psychological and psychiatric services), justice or parole;
(d) a person who provides services for, or on behalf of:
(i) a State or Territory; or
(ii) an authority of a State or Territory;
in relation to corrective services (including prison medical, psychological and psychiatric services), justice or parole;
(e) the Director of Public Prosecutions or a person performing a similar function under a law of a State or Territory;
(f) a member of the staff of the Office of the Director of Public Prosecutions (within the meaning of the Director of Public Prosecutions Act 1983) or of a similar body established under a law of a State or Territory;
(g) the Director‑General of the Australian Security Intelligence Organisation, a Deputy Director‑General of the Australian Security Intelligence Organisation, an ASIO employee or an ASIO affiliate (all within the meaning of the Australian Security Intelligence Organisation Act 1979);
(h) an APS employee of a Department administered by the Minister administering:
(i) the Migration Act 1958; or
(ii) the Australian Citizenship Act 2007;
(i) a person:
(i) who is an authorised officer (within the meaning of Division 9A of Part IB of the Crimes Act 1914); or
(ii) who, under a delegation from such an authorised officer, exercises powers or performs functions of the authorised officer under Division 9A of Part IB of the Crimes Act 1914;
(j) a person who is a relevant expert and who is:
(i) appointed by the AFP Minister under section 105A.18D of the Code; or
(ii) otherwise engaged, by the AFP Minister, or a person on behalf of the AFP Minister;
to assess the risk of a terrorist offender committing a serious Part 5.3 offence (all within the meaning of Division 105A of the Code) for the purposes of that Division (whether or not an application for a post‑sentence order has been made).
Part 3—Dangers to the community
Division 1—Serious drugs and precursors
11 Controlled drugs
Each item of the table in clause 1 of Schedule 1 lists:
(a) for the purposes of paragraph 301.1(1)(a) of the Code, a substance that is a controlled drug; and
(b) for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity that is the commercial quantity of the controlled drug; and
(c) for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity (if any) that is the marketable quantity of the controlled drug; and
(d) for the purposes of paragraph (a) of item 1 of the table in section 301.12 of the Code, the quantity that is the trafficable quantity of the controlled drug.
12 Controlled plants
Each item of the following table lists:
(a) for the purposes of paragraph 301.2(1)(a) of the Code, a growing plant that is a controlled plant; and
(b) for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, a quantity that is a commercial quantity of the controlled plant; and
(c) for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, a quantity that is a marketable quantity of the controlled plant; and
(d) for the purposes of paragraph (a) of item 1 of the table in section 301.12 of the Code, a quantity that is a trafficable quantity of the controlled plant.
| Controlled plants and quantities | ||||
| Item | Controlled plant | Commercial quantity | Marketable quantity | Trafficable quantity |
| 1 | Any plant of the genus Cannabis | 250 kg or 1,000 plants | 25 kg or 100 plants | 250 g or 10 plants |
13 Controlled precursors
Each item of the following table lists:
(a) for the purposes of paragraph 301.3(1)(a) of the Code, a substance that is a controlled precursor; and
(b) for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity that is the commercial quantity of the controlled precursor; and
(c) for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity that is the marketable quantity of the controlled precursor.
Note: A salt or ester of a substance listed in the table is also a controlled precursor: see paragraph 301.3(1)(b) of the Code.
| Controlled precursors and quantities | |||
| Item | Controlled precursor | Commercial quantity (kilograms) | Marketable quantity (grams) |
| 1A | Alpha‑Phenylacetoacetamide (APAA) | 2.75 | 915.0 |
| 1B | Alpha‑Phenylacetoacetonitrile (APAAN) | 1.76 | 587.0 |
| 1C | 4‑Anilino‑N‑phenethylpiperidine (ANPP) | 0.006 | 2.77 |
| 1 | Ephedrine | 1.2 | 400.0 |
| 2 | Ergometrine | 0.006 | 0.15 |
| 3 | Ergotamine | 0.01 | 0.25 |
| 4 | Isosafrole | 1.45 | 290.0 |
| 5 | Lysergic acid | 0.003 | 0.075 |
| 5A | Methyl alpha‑phenylacetoacetate (MAPA) | 3.06 | 1,020.0 |
| 6 | 3,4‑Methylenedioxyphenylacetic acid | 1.5 | 300.0 |
| 6A | 3‑(3’, 4’‑Methylenedioxyphenyl)‑2‑methyl glycidic acid, sodium salt (NaMDMG) | 1.46 | 292.0 |
| 7 | 3,4‑Methylenedioxyphenyl‑2‑propanone | 0.75 | 150.0 |
| 7A | Methyl 3‑(3’, 4’‑methylenedioxyphenyl)‑2‑methyl glycidate (MMDMG) | 1.23 | 246.0 |
| 7B | Methyl 3‑phenyl‑2‑methyl glycidate | 2.96 | 980.0 |
| 7C | N‑Phenethyl‑4‑piperidone (NPP) | 0.008 | 4.0 |
| 8 | Phenylacetic acid | 4.05 | 1,350.0 |
| 8A | 3‑Phenyl‑2‑methyl glycidic acid, sodium salt | 5.17 | 1,720.0 |
| 9 | Phenylpropanolamine | 1.2 | 400.0 |
| 10 | Phenyl‑2‑propanone | 1.04 | 340.0 |
| 10A | Phenyl‑2‑propanone bisulphite | 2.64 | 880.0 |
| 11 | Piperonal | 1.6 | 320.0 |
| 12 | Pseudoephedrine | 1.2 | 400.0 |
| 13 | Safrole | 2.85 | 570.0 |
14 Border controlled drugs
Each item of the table in clause 1 of Schedule 2 lists:
(a) for the purposes of paragraph 301.4(a) of the Code, a substance that is a border controlled drug; and
(b) for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity that is the commercial quantity of the border controlled drug; and
(c) for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity that is the marketable quantity of the border controlled drug.
15 Border controlled plants
Each item of the following table lists:
(a) for the purposes of paragraph 301.5(a) of the Code, a growing plant that is a border controlled plant; and
(b) for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, a quantity (if any) that is a commercial quantity of the border controlled plant; and
(c) for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, a quantity (if any) that is a marketable quantity of the border controlled plant.
| Border controlled plants and quantities | |||
| Item | Border controlled plant | Commercial quantity | Marketable quantity |
| 1 | Any plant of the genus Cannabis | 250 kg or 1,000 plants | 25 kg or 100 plants |
| 2 | Any plant of the genus Erythroxylon (also known as Erythroxylum) from which cocaine can be extracted either directly or by chemical transformation | 80 kg | |
| 3 | Any plant of the genus Lophophora | ||
| 4 | Any plant of the species Papaver bracteatum | 10 kg | |
| 5 | Any plant of the species Papaver somniferum | 10 kg | |
| 6 | Any plant of the species Piptagenia peregrine | ||
| 7 | Any plant of the species Psilocybe | ||
16 Border controlled precursors
Each item of the following table lists:
(a) for the purposes of paragraph 301.6(1)(a) of the Code, a substance that is a border controlled precursor; and
(b) for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity (if any) that is the commercial quantity of the border controlled precursor; and
(c) for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity (if any) that is the marketable quantity of the border controlled precursor.
Note: A salt or ester of a substance listed in the table and an immediate precursor of a substance listed in the table are also border controlled precursors: see paragraphs 301.6(1)(b) and (c) of the Code.
| Border controlled precursors and quantities | |||
| Item | Border controlled precursor | Commercial quantity (kilograms) | Marketable quantity (grams) |
| 1 | N‑Acetylanthranilic acid | ||
| 1A | Alpha‑Phenylacetoacetamide (APAA) | 2.74 | 7.3 |
| 1B | Alpha‑Phenylacetoacetonitrile (APAAN) | 1.76 | 4.7 |
| 1C | 4‑Anilino‑N‑phenethylpiperidine (ANPP) | 0.006 | 0.006 |
| 2 | Any plant of the species Ephedra | ||
| 2A | Chloroephedrine | 1.153 | 3.07 |
| 2B | Chloropseudoephedrine | 1.153 | 3.07 |
| 3 | Ephedrine | 1.2 | 3.2 |
| 4 | Ergometrine | 0.006 | 0.006 |
| 5 | Ergotamine | 0.01 | 0.01 |
| 6 | Isosafrole | 1.45 | 1.45 |
| 7 | Lysergic acid | 0.003 | 0.003 |
| 7A | Methyl alpha‑phenylacetoacetate (MAPA) | 3.06 | 8.2 |
| 7B | 3‑(3’, 4’‑Methylenedioxyphenyl)‑2‑methyl glycidic acid, sodium salt (NaMDMG) | 1.46 | 14.6 |
| 8 | 3,4‑Methylenedioxyphenyl‑2‑propanone | 0.75 | 0.75 |
| 8A | Methyl 3‑(3’, 4’‑methylenedioxyphenyl)‑2‑methyl glycidate (MMDMG) | 1.23 | 12.3 |
| 8B | Methyl 3‑phenyl‑2‑methyl glycidate | 2.96 | 7.9 |
| 8C | N‑Phenethyl‑4‑piperidone (NPP) | 0.008 | 0.008 |
| 9 | Phenylacetic acid | 4.05 | 10.8 |
| 9A | 3‑Phenyl‑2‑methyl glycidic acid, sodium salt | 5.17 | 13.7 |
| 10 | Phenylpropanolamine | 1.2 | 3.2 |
| 11 | Phenyl‑2‑propanone | 1.04 | 2.7 |
| 11A | Phenyl‑2‑propanone bisulphite | 2.64 | 7.04 |
| 12 | Piperonal | 1.6 | 1.6 |
| 13 | Pseudoephedrine | 1.2 | 3.2 |
| 14 | Safrole | 2.85 | 2.85 |
Division 2—Psychoactive substances
17 Importing psychoactive substances
For the purposes of paragraph 320.2(2)(l) of the Code, a substance that is imported into Australia in accordance with the conditions set out in section 19 of this instrument is prescribed.
18 Importing substances represented to be serious drug alternatives
For the purposes of paragraph 320.3(3)(f) of the Code, a substance that is imported into Australia in accordance with the conditions set out in section 19 of this instrument is prescribed.
19 Conditions for importing certain substances
(1) For the purposes of sections 17 and 18, the conditions are that:
(a) the person importing the substance (the importer) is the holder of a licence to import drugs granted by the Health Secretary or an authorised person under subregulation 5(5) of the Customs (Prohibited Imports) Regulations 1956; and
(b) the importer is covered by subsection (2); and
(c) before the substance is imported, the importer gives the Health Secretary or an authorised person a written notice about the proposed importation that includes:
(i) the identity and amount of the substance being imported; and
(ii) the purpose of the importation; and
(iii) a 30‑day period during which the importation is likely to occur; and
(iv) the importer’s name and import licence number; and
(v) if paragraph (2)(a), (d), (e) or (f) applies and the importer is employed by the body mentioned in the applicable paragraph—the name of the importer’s employer; and
(vi) any other information required by the Health Secretary.
(2) For the purposes of paragraph (1)(b), the importer is covered by this subsection if:
(a) the importer is, or is employed by, a forensic laboratory and is importing the substance for the purposes of forensic analysis; or
(b) the importer is the Australian Federal Police, or a police force of a State or Territory, and is importing the substance for the purposes of law enforcement; or
(c) the importer is the Commissioner or a Deputy Commissioner of the Australian Federal Police, or is the head or deputy head (however described) of a police force of a State or Territory, and is importing the substance for the purposes of law enforcement; or
(d) the importer is, or is employed by, a medical research facility and is importing the substance for the purposes of medical research; or
(e) the importer is, or is employed by, a scientific research facility and is importing the substance for the purposes of scientific research; or
(f) all of the following apply:
(i) the importer is, or is employed by, an entity that imports drugs (within the meaning of subregulation 5(20) of the Customs (Prohibited Imports) Regulations 1956) on behalf of a person or body mentioned in paragraph (a), (b), (c), (d) or (e);
(ii) the person or body holds a licence of a kind mentioned in paragraph (1)(a);
(iii) the importer is importing the substance at the written request of the person or body.
(3) For the purposes of paragraph (1)(c), the Health Secretary may determine:
(a) information to be included in a notice; and
(b) the way a notice may be given to the Health Secretary or an authorised person.
Division 3—Cross‑border firearms trafficking
20 Firearm law
For the purposes of the definition of firearm law in subsections 360.2(3) and 360.3(2) of the Code, the following laws are prescribed:
(a) the Firearms Act 1996 (NSW);
(b) the Firearms Act 1996 (Vic.);
(c) the Weapons Act 1990 (Qld);
(d) the Firearms Act 1973 (WA);
(e) the Firearms Act 2015 (SA);
(f) the Firearms Act 1996 (Tas.);
(g) the Firearms Act 1996 (ACT);
(h) the Firearms Act 1997 (NT);
(i) the Firearms and Prohibited Weapons Act 1997 (Norfolk Island);
(j) any regulations made under any of the Acts referred to in paragraphs (a) to (i).
Part 4—National infrastructure
21 Dangerous or harmful substances and things that must not be carried by post
For the purposes of subparagraph 471.15(1)(b)(ii) of the Code, the following are dangerous or harmful substances or things that must not, without exception, be carried by post:
(a) gas that is so toxic or corrosive to humans as to pose a hazard to health;
(b) a thermally unstable substance that is likely to undergo a strongly exothermic decomposition;
(c) a substance that ignites or self‑heats when in contact with air.
Part 5—Application, saving and transitional provisions
Division 1—Provisions for this instrument as originally made
22 Things done under the Criminal Code Regulations 2002
(1) If:
(a) a thing was done for a particular purpose under the Criminal Code Regulations 2002 as in force immediately before those Regulations were repealed; and
(b) the thing could be done for that purpose under this instrument;
the thing has effect for the purposes of this instrument as if it had been done for that purpose under this instrument.
(2) Without limiting subsection (1), a reference in that subsection to a thing being done includes a reference to a notice, application or other instrument being given or made.
23 Conduct, event, circumstances occurring before commencement
(1) To avoid doubt, a function or duty may be performed, or a power exercised, under this instrument in relation to conduct engaged in, an event that occurred, or a circumstance that arose, before this section commences.
(2) This section does not limit section 22 of this instrument or section 7 of the Acts Interpretation Act 1901 (as that Act applies in relation to this instrument because of paragraph 13(1)(a) of the Legislation Act 2003).
Schedule 1—Controlled drugs
Note: See section 11.
1 Controlled drugs and quantities
The following table lists substances that are controlled drugs and the quantities of those drugs that are commercial quantities, marketable quantities and trafficable quantities.
Note: A drug analogue of a substance listed in the table is also a controlled drug (see paragraph 301.1(1)(b) of the Code).
| Controlled drugs and quantities | ||||
| Item | Controlled drug | Commercial quantity (kilograms) | Marketable quantity (grams) | Trafficable quantity (grams) |
| 1 | Acetorphine | 2.0 | 250.0 | 2.0 |
| 2 | 4‑Acetoxy‑N, N‑dimethyltryptamine (4‑AcO‑DMT) | 2.0 | 250.0 | 2.0 |
| 3 | 4‑Acetoxy‑N‑methyl‑N‑ethyltryptamine (4‑AcO‑MET) | 2.0 | 250.0 | 2.0 |
| 4 | Acetyl‑alpha‑methylfentanyl | 0.005 | 2.5 | 0.005 |
| 5 | Acetylcodeine | 2.0 | 250.0 | 2.0 |
| 6 | Acetyldihydrocodeine | 2.0 | 250.0 | 2.0 |
| 7 | Acetylmethadol | 2.0 | 250.0 | 2.0 |
| 8 | Allylprodine | 2.0 | 250.0 | 2.0 |
| 9 | Alphacetylmethadol | 10.0 | 5,000.0 | 10.0 |
| 10 | Alphameprodine | 0.2 | 100.0 | 0.2 |
| 11 | Alphamethadol | 0.2 | 100.0 | 0.2 |
| 12 | alpha‑Methylfentanyl | 0.005 | 2.5 | 0.005 |
| 13 | alpha‑Methylthiofentanyl | 0.005 | 2.5 | 0.005 |
| 14 | Alphaprodine | 25.0 | 12,500.0 | 25.0 |
| 15 | alpha‑Pyrrolidinobutiophenone (α‑PBP) | 0.75 | 250.0 | 0.75 |
| 16 | alpha‑Pyrrolidinopropiophenone (α‑PPP) | 0.75 | 250.0 | 0.75 |
| 17 | alpha‑Pyrrolidinovalerophenone (α‑PVP) | 0.75 | 250.0 | 0.75 |
| 18 | 5‑(2‑Aminopropyl)‑2,3‑dihydro‑1h‑indene (5‑APDI) | 0.75 | 250.0 | 0.75 |
| 19 | 6‑(2‑Aminopropyl)‑2,3‑dihydrobenzofuran (6‑APDB) | 0.75 | 250.0 | 0.75 |
| 20 | Amphetamine | 0.75 | 250.0 | 2.0 |
| 21 | Anileridine | 25.0 | 12,500.0 | 25.0 |
| 22 | Barbiturates | 5.0 | 5.0 | |
| 23 | Benzethidine | 10.0 | 5,000.0 | 10.0 |
| 24 | 1‑(Benzofuran‑6‑yl) propan‑2‑amine (6‑APB) | 0.75 | 250.0 | 0.75 |
| 25 | Benzoylecgonine | 2.0 | 250.0 | 2.0 |
| 26 | Benzylmorphine | 5.0 | 2,500.0 | 5.0 |
| 27 | Benzylpiperazine | 0.75 | 250.0 | 2.0 |
| 28 | Betacetylmethadol | 5.0 | 2,500.0 | 5.0 |
| 29 | beta‑Hydroxyfentanyl | 0.005 | 2.5 | 0.005 |
| 30 | beta‑Hydroxy‑3‑methylfentanyl | 0.005 | 2.5 | 0.005 |
| 31 | beta‑Keto‑methylbenzodioxolylpentanamine (pentylone) | 0.75 | 250.0 | 0.75 |
| 32 | beta‑Keto‑N‑methyl‑3,4‑ benzodioxyolylbutanamine (butylone) | 0.75 | 250.0 | 0.75 |
| 33 | Betameprodine | 5.0 | 2,500.0 | 5.0 |
| 34 | Betamethadol | 5.0 | 2,500.0 | 5.0 |
| 35 | Betaprodine | 5.0 | 2,500.0 | 5.0 |
| 36 | Bezitramide | 5.0 | 2,500.0 | 5.0 |
| 37 | 2‑Bromoamphetamine | 0.75 | 250.0 | 0.75 |
| 38 | 3‑Bromoamphetamine | 0.75 | 250.0 | 0.75 |
| 39 | 4‑Bromoamphetamine | 0.75 | 250.0 | 0.75 |
| 40 | 4‑Bromo‑2,5‑dimethoxyamphetamine | 0.5 | 100.0 | 0.5 |
| 41 | 2‑Bromo‑5‑methoxymethcathinone | 0.75 | 250.0 | 0.75 |
| 42 | 2‑Bromomethamphetamine | 0.75 | 250.0 | 0.75 |
| 43 | 3‑Bromomethamphetamine | 0.75 | 250.0 | 0.75 |
| 44 | 4‑Bromomethamphetamine | 0.75 | 250.0 | 0.75 |
| 45 | 2‑Bromomethcathinone | 0.75 | 250.0 | 0.75 |
| 46 | 3‑Bromomethcathinone | 0.75 | 250.0 | 0.75 |
| 47 | 4‑Bromomethcathinone | 0.75 | 250.0 | 0.75 |
| 48 | Bufotenine | 2.0 | 250.0 | 2.0 |
| 49 | Bupropion | 0.75 | 250.0 | 0.75 |
| 50 | Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre) | 125.0 | 25,000.0 | 250.0 |
| 51 | Cannabis resin | 125.0 | 25,000.0 | 20.0 |
| 52 | Cathinone | 0.75 | 250.0 | 0.75 |
| 53 | 1‑(4‑Chloro‑2,5‑dimethoxyphenyl)‑2‑ ethenamine (2C‑C) | 0.5 | 100.0 | 0.5 |
| 54 | 2‑Chloroamphetamine | 0.75 | 250.0 | 0.75 |
| 55 | 3‑Chloroamphetamine | 0.75 | 250.0 | 0.75 |
| 56 | 4‑Chloroamphetamine | 0.75 | 250.0 | 0.75 |
| 57 | 2‑Chloromethamphetamine | 0.75 | 250.0 | 0.75 |
| 58 | 3‑Chloromethamphetamine | 0.75 | 250.0 | 0.75 |
| 59 | 4‑Chloromethamphetamine | 0.75 | 250.0 | 0.75 |
| 60 | 4‑Chloro‑N‑ethylamphetamine | 0.75 | 250.0 | 0.75 |
| 61 | 2‑Chloromethcathinone | 0.75 | 250.0 | 0.75 |
| 62 | 3‑Chloromethcathinone | 0.75 | 250.0 | 0.75 |
| 63 | 4‑Chloromethcathinone | 0.75 | 250.0 | 0.75 |
| 64 | 4‑Chlorophenyl‑1‑methoxypropan‑2‑amine | 0.75 | 250.0 | 0.75 |
| 65 | Chlorphentermine | 2.0 | 250.0 | 2.0 |
| 66 | Clonitazene | 5.0 | 100.0 | 5.0 |
| 67 | Cocaine | 2.0 | 250.0 | 2.0 |
| 68 | Codeine | 10.0 | 5,000.0 | 10.0 |
| 69 | Codeine‑N‑oxide | 10.0 | 5,000.0 | 10.0 |
| 70 | Codoxime | 10.0 | 5,000.0 | 10.0 |
| 71 | Desomorphine | 2.0 | 250.0 | 2.0 |
| 72 | Dexamphetamine | 2.0 | 250.0 | 2.0 |
| 73 | Dextromoramide | 2.0 | 250.0 | 2.0 |
| 74 | Diampromide | 5.0 | 2,500.0 | 5.0 |
| 75 | Diethylpropion (N, N‑Diethylcathinone) | 5.0 | 2,500.0 | 5.0 |
| 76 | Diethylthiambutene | 5.0 | 2,500.0 | 5.0 |
| 77 | N,N‑Diethyltryptamine | 2.0 | 250.0 | 2.0 |
| 78 | Difenoxin | 2.0 | 250.0 | 2.0 |
| 79 | 1‑(2,3‑Dihydro‑1‑benzofuran‑5‑yl)propan‑2‑ amine (5‑APDB) | 0.75 | 250.0 | 0.75 |
| 80 | Dihydrocodeine | 10.0 | 5,000.0 | 10.0 |
| 81 | Dihydromorphine | 10.0 | 5,000.0 | 10.0 |
| 82 | Dimenoxadol | 10.0 | 5,000.0 | 10.0 |
| 83 | Dimepheptanol | 10.0 | 5,000.0 | 10.0 |
| 84 | 2,5‑Dimethoxy‑4‑bromophenethylamine (2C‑B) | 0.5 | 100.0 | 0.5 |
| 85 | 2,5‑Dimethoxy‑4‑ethylphenethylamine (2C‑E) | 0.5 | 100.0 | 0.5 |
| 86 | 2,5‑Dimethoxy‑4‑iodophenethylamine (2C‑I) | 0.5 | 100.0 | 0.5 |
| 87 | 2,5‑Dimethoxy‑4‑methylamphetamine (STP, DOM) | 0.75 | 250 | 0.75 |
| 88 | 2,5‑Dimethoxy‑4‑methylphenethylamine (2C‑D) | 0.5 | 100.0 | 0.5 |
| 89 | 2,5‑Dimethoxy‑4‑nitrophenethylamine (2C‑N) | 0.5 | 100.0 | 0.5 |
| 90 | 2,5‑Dimethoxy‑4‑(n)‑propylphenethylamine (2C‑P) | 0.5 | 100.0 | 0.5 |
| 91 | 3,4‑Dimethoxymethcathinone | 0.75 | 250.0 | 0.75 |
| 92 | 1‑Dimethylamino‑1,2‑diphenylethane | 5.0 | 2,500.0 | 5.0 |
| 93 | N,N‑Dimethylamphetamine | 0.75 | 250.0 | 0.75 |
| 94 | N, N‑Dimethylcathinone | 0.75 | 250.0 | 0.75 |
| 95 | 1,1‑Dimethylheptyl‑11‑ hydroxytetrahydrocannabinol (HU‑210) | 5.0 | 1,000.0 | 5.0 |
| 96 | 3,4‑Dimethylmethcathinone | 0.75 | 250.0 | 0.75 |
| 97 | Dimethylthiambutene | 20.0 | 10,000.0 | 20.0 |
| 98 | N,N‑Dimethyltryptamine | 2.0 | 250.0 | 2.0 |
| 99 | Dioxaphetyl butyrate | 2.0 | 250.0 | 2.0 |
| 100 | Diphenoxylate | 2.0 | 250.0 | 2.0 |
| 101 | Dipipanone | 10.0 | 5,000.0 | 10.0 |
| 102 | Drotebanol | 2.0 | 250.0 | 2.0 |
| 103 | Ecgonine | 10.0 | 5,000.0 | 10.0 |
| 104 | Ethchlorvynol | 50.0 | 50.0 | |
| 105 | Ethinamate | 50.0 | 50.0 | |
| 106 | N‑Ethylcathinone | 0.75 | 250.0 | 0.75 |
| 107 | Ethylmethylthiambutene | 10.0 | 5,000.0 | 10.0 |
| 108 | Ethylmorphine | 2.0 | 250.0 | 2.0 |
| 109 | 3‑(2‑Ethylphenyl)‑2‑methyl‑quinazolin‑4‑one (Etaqualone) | 5.0 | 5.0 | |
| 110 | Etonitazene | 5.0 | 2,500.0 | 5.0 |
| 111 | Etorphine | 5.0 | 2,500.0 | 5.0 |
| 112 | Etoxeridine | 5.0 | 2,500.0 | 5.0 |
| 113 | Fentanyl | 0.005 | 2.5 | 0.005 |
| 114 | 4‑Fluoro‑2,5‑dimethoxyphenethylamine (2C‑F) | 0.5 | 100.0 | 0.5 |
| 115 | 2‑Fluoroamphetamine | 0.75 | 250.0 | 0.75 |
| 116 | 3‑Fluoroamphetamine | 0.75 | 250.0 | 0.75 |
| 117 | 4‑Fluoroamphetamine | 0.75 | 250.0 | 0.75 |
| 118 | 2‑Fluoromethamphetamine | 0.75 | 250.0 | 0.75 |
| 119 | 3‑Fluoromethamphetamine | 0.75 | 250.0 | 0.75 |
| 120 | 4‑Fluoromethamphetamine | 0.75 | 250.0 | 0.75 |
| 121 | 2‑Fluoromethcathinone | 0.75 | 250.0 | 0.75 |
| 122 | 3‑Fluoromethcathinone | 0.75 | 250.0 | 0.75 |
| 123 | 4‑Fluoromethcathinone | 0.75 | 250.0 | 0.75 |
| 124 | Furethidine | 1.0 | 500.0 | 1.0 |
| 125 | Gammabutyrolactone (GBL) | 1.0 | 250.0 | 0.5 |
| 126 | Glutethimide | 50.0 | 50.0 | |
| 127 | Heroin (diacetylmorphine) | 1.5 | 250.0 | 2.0 |
| 128 | Hydrocodone | 2.0 | 250.0 | 2.0 |
| 129 | Hydromorphinol | 2.0 | 250.0 | 2.0 |
| 130 | Hydromorphone | 2.0 | 250.0 | 2.0 |
| 131 | Hydroxyamphetamine | 2.0 | 250.0 | 2.0 |
| 132 | 4‑Hydroxybutanoic acid (GHB) | 1.0 | 250.0 | 0.5 |
| 133 | p‑Hydroxyephedrine | 2.0 | 250.0 | 2.0 |
| 134 | Hydroxypethidine | 0.75 | 250.0 | 0.75 |
| 135 | 2‑Iodoamphetamine | 0.75 | 250.0 | 0.75 |
| 136 | 3‑Iodoamphetamine | 0.75 | 250.0 | 0.75 |
| 137 | 4‑Iodoamphetamine | 0.75 | 250.0 | 0.75 |
| 138 | 2‑Iodomethamphetamine | 0.75 | 250.0 | 0.75 |
| 139 | 3‑Iodomethamphetamine | 0.75 | 250.0 | 0.75 |
| 140 | 4‑Iodomethamphetamine | 0.75 | 250.0 | 0.75 |
| 141 | 2‑Iodomethcathinone | 0.75 | 250.0 | 0.75 |
| 142 | 3‑Iodomethcathinone | 0.75 | 250.0 | 0.75 |
| 143 | 4‑Iodomethcathinone | 0.75 | 250.0 | 0.75 |
| 144 | Isomethadone | 2.0 | 250.0 | 2.0 |
| 145 | 4‑Isopropoxy‑2,5‑dimethoxyphenethylamine (2C‑O‑4) | 0.5 | 100.0 | 0.5 |
| 146 | Ketamine | 1.0 | 500.0 | 3.0 |
| 147 | Ketobemidone | 2.0 | 250.0 | 2.0 |
| 148 | Levomethorphan | 2.0 | 250.0 | 2.0 |
| 149 | Levophenacylmorphan | 2.0 | 250.0 | 2.0 |
| 150 | Levorphanol, but not including dextrorphan | 1.0 | 500.0 | 1.0 |
| 151 | Lysergamides | 0.01 | 0.01 | |
| 152 | Lysergide (LSD) | 0.002 | 0.05 | 0.002 |
| 153 | Meprobamate | 50.0 | 50.0 | |
| 154 | Mescaline | 7.5 | 3.75 | 7.5 |
| 155 | Metazocine | 7.0 | 3,500.0 | 7.0 |
| 156 | Methadone | 2.0 | 250.0 | 2.0 |
| 157 | Methamphetamine | 0.75 | 250.0 | 2.0 |
| 158 | Methaqualone | 5.0 | 5.0 | |
| 159 | Methcathinone | 0.75 | 250.0 | 2.0 |
| 160 | Methorphan, but not including dextromethorphan | 2.0 | 250.0 | 2.0 |
| 161 | 4’‑Methoxy‑alpha‑pyrrolidinopropiophenone (MOPPP) | 0.75 | 250.0 | 0.75 |
| 162 | 4‑Methoxyamphetamine | 0.75 | 250.0 | 0.75 |
| 163 | 4‑Methoxymethamphetamine | 0.75 | 250.0 | 0.75 |
| 164 | 4‑Methoxymethcathinone | 0.75 | 250.0 | 0.75 |
| 165 | 4’‑Methyl‑alpha‑pyrrolidinobutiophenone (MPBP) | 0.75 | 250.0 | 0.75 |
| 166 | 4’‑Methyl‑alpha‑pyrrolidinohexiophenone (MPHP) | 0.75 | 250.0 | 0.75 |
| 167 | 4’‑Methyl‑alpha‑pyrrolidinopropiophenone (MPPP) | 0.75 | 250.0 | 0.75 |
| 168 | 2‑Methylamino‑1‑phenylbutan‑1‑ one (buphedrone) | 0.75 | 250.0 | 0.75 |
| 169 | 4‑Methylamphetamine | 0.75 | 250.0 | 0.75 |
| 170 | N‑Methyl butylone | 0.75 | 250.0 | 0.75 |
| 171 | Methyldesorphine | 2.0 | 250.0 | 2.0 |
| 172 | Methyldihydromorphine | 2.0 | 250.0 | 2.0 |
| 173 | 3,4‑Methylenedioxyamphetamine (MDA) | 0.75 | 100.0 | 0.5 |
| 174 | 3,4‑Methylenedioxymethamphetamine (MDMA) | 0.5 | 100.0 | 0.5 |
| 175 | 3,4‑Methylenedioxyethcathinone (MDEC) | 0.75 | 250.0 | 0.75 |
| 176 | 3,4‑Methylenedioxymethcathinone (MDMC) | 0.75 | 250.0 | 0.75 |
| 177 | 3,4‑Methylenedioxypyrovalerone (MDPV) | 0.75 | 250.0 | 0.75 |
| 178 | 3’,4’‑Methylenedioxy‑alpha‑ pyrrolidinobutiophenone (MDPBP) | 0.75 | 250.0 | 0.75 |
| 179 | 3’,4’‑Methylenedioxy‑alpha‑ pyrrolidinopropiophenone (MDPPP) | 0.75 | 250.0 | 0.75 |
| 180 | 4‑Methylethcathinone | 0.75 | 250.0 | 0.75 |
| 181 | 3‑Methylfentanyl | 0.005 | 2.5 | 0.005 |
| 182 | 4‑Methylmethamphetamine | 0.75 | 250.0 | 0.75 |
| 183 | 4‑Methylmethcathinone (4‑MMC) | 0.75 | 250.0 | 2.0 |
| 184 | Methylphenidate | 2.0 | 250.0 | 2.0 |
| 185 | 1‑Methyl‑4‑phenyl‑4‑propionoxypiperidine (MPPP) | 2.0 | 250.0 | 2.0 |
| 186 | 4‑Methylthioamphetamine (4‑MTA) | 0.75 | 250.0 | 0.75 |
| 187 | 4‑Methylthiobutylamphetamine (4‑MTBA) | 0.75 | 250.0 | 0.75 |
| 188 | 4‑Methylthiodimethamphetamine (4‑MTDMA) | 0.75 | 250.0 | 0.75 |
| 189 | 4‑Methylthioethylamphetamine (4‑MTEA) | 0.75 | 250.0 | 0.75 |
| 190 | 3‑Methylthiofentanyl | 0.005 | 2.5 | 0.005 |
| 191 | 4‑Methylthiomethamphetamine (4‑MTMA) | 0.75 | 250.0 | 0.75 |
| 192 | 4‑Methylthiopropylamphetamine (4‑MTPA) | 0.75 | 250.0 | 0.75 |
| 193 | Methyprylon | 50.0 | 50.0 | |
| 194 | Metopon | 2.0 | 250.0 | 2.0 |
| 195 | Monoacetylmorphines | 2.0 | 250.0 | 2.0 |
| 196 | Moramide | 2.0 | 250.0 | 2.0 |
| 197 | Morphan, but not including dextrorphan | 2.0 | 250.0 | 2.0 |
| 198 | Morpheridine | 2.0 | 250.0 | 2.0 |
| 199 | Morphine | 1.5 | 250.0 | 1.5 |
| 200 | Morphine‑N‑oxide | 2.0 | 250.0 | 2.0 |
| 201 | Myrophine | 20.0 | 20.0 | |
| 202 | Nicocodine | 2.0 | 250.0 | 2.0 |
| 203 | Nicodicodine | 2.0 | 250.0 | 2.0 |
| 204 | Nicomorphine | 2.0 | 250.0 | 2.0 |
| 205 | Noracymethadol | 2.0 | 250.0 | 2.0 |
| 206 | Norcodeine | 2.0 | 250.0 | 2.0 |
| 207 | Norlevorphanol | 2.0 | 250.0 | 2.0 |
| 208 | Normethadone | 5.0 | 2,500.0 | 5.0 |
| 209 | Normorphine | 20.0 | 20.0 | |
| 210 | Norpipanone | 10.0 | 5,000.0 | 10.0 |
| 211 | Opium | 20.0 | 10,000.0 | 20.0 |
| 212 | Oripavine | 2.0 | 250.0 | 2.0 |
| 213 | Oxycodone | 5.0 | 2,500.0 | 5.0 |
| 214 | Oxymorphone | 2.0 | 250.0 | 2.0 |
| 215 | para‑Fluorofentanyl | 0.005 | 2.5 | 0.005 |
| 216 | Pentazocine | 20.0 | 20.0 | |
| 217 | Pethidine | 10.0 | 5,000.0 | 10.0 |
| 218 | Phenadoxone | 10.0 | 5,000.0 | 10.0 |
| 219 | Phenampromide | 10.0 | 5,000.0 | 10.0 |
| 220 | Phenazocine | 1.0 | 500.0 | 1.0 |
| 221 | Phencyclidine | 2.0 | 250.0 | 2.0 |
| 222 | Phendimetrazine | 5.0 | 2,500.0 | 5.0 |
| 223 | Phenmetrazine | 5.0 | 2,500.0 | 5.0 |
| 224 | Phenomorphan | 5.0 | 2,500.0 | 5.0 |
| 225 | Phenoperidine | 1.0 | 500.0 | 1.0 |
| 226 | Phentermine | 5.0 | 2,500.0 | 5.0 |
| 227 | 1‑Phenylethyl‑4‑phenyl‑4‑acetoxypiperidine (PEPAP) | 2.0 | 250.0 | 2.0 |
| 228 | Pholcodine | 5.0 | 2,500.0 | 5.0 |
| 229 | Piminodine | 10.0 | 5,000.0 | 10.0 |
| 230 | Pipradrol | 1.0 | 500.0 | 1.0 |
| 231 | Piritramide | 1.0 | 500.0 | 1.0 |
| 232 | Proheptazine | 1.0 | 500.0 | 1.0 |
| 233 | Properidine | 25.0 | 12,500.0 | 25.0 |
| 234 | Propiram | 10.0 | 5,000.0 | 10.0 |
| 235 | Psilocine | 2.0 | 1,000.0 | 2.0 |
| 236 | Psilocybine | 2.0 | 1,000.0 | 2.0 |
| 237 | Pyrovalerone | 0.75 | 250.0 | 0.75 |
| 238 | Tetrahydrocannabinols (THC) | 5.0 | 1,000.0 | 2.0 |
| 239 | Thebacon | 2.0 | 250.0 | 2.0 |
| 240 | Thebaine | 2.0 | 250.0 | 2.0 |
| 241 | Thiofentanyl | 0.005 | 2.5 | 0.005 |
| 242 | Trimeperidine | 10.0 | 5,000.0 | 10.0 |
| 243 | 2,3,4‑Trimethoxyamphetamine | 0.75 | 250.0 | 0.75 |
| 244 | 2,3,5‑Trimethoxyamphetamine | 0.75 | 250.0 | 0.75 |
| 245 | 2,3,6‑Trimethoxyamphetamine | 0.75 | 250.0 | 0.75 |
| 246 | 2,4,5‑Trimethoxyamphetamine | 0.75 | 250.0 | 0.75 |
| 247 | 2,4,6‑Trimethoxyamphetamine | 0.75 | 250.0 | 0.75 |
| 248 | 3,4,5‑Trimethoxyamphetamine | 0.75 | 250.0 | 0.75 |
| 249 | 2,4,5‑Trimethoxyphenethylamine (2C‑O) | 0.5 | 100.0 | 0.5 |
Schedule 2—Border controlled drugs
Note: See section 14.
1 Border controlled drugs and quantities
The following table lists substances that are border controlled drugs and the quantities of those drugs that are commercial quantities and marketable quantities.
Note: A drug analogue of a substance listed in the table is also a border controlled drug (see paragraph 301.4(b) of the Code).
| Border controlled drugs and quantities | |||
| Item | Border controlled drug | Commercial quantity (kilograms) | Marketable quantity (grams) |
| 1 | Acetorphine | 2.0 | 2.0 |
| 2 | Acetyl‑alpha‑methylfentanyl | 0.005 | 0.005 |
| 3 | Acetylcodeine | 2.0 | 2.0 |
| 4 | Acetyldihydrocodeine | 2.0 | 2.0 |
| 5 | Acetylmethadol | 2.0 | 2.0 |
| 6 | Allylprodine | 2.0 | 2.0 |
| 7 | Alphacetylmethadol | 10.0 | 10.0 |
| 8 | Alphameprodine | 0.2 | 0.2 |
| 9 | Alphamethadol | 0.2 | 0.2 |
| 10 | alpha‑Methylfentanyl | 0.005 | 0.005 |
| 11 | alpha‑Methylthiofentanyl | 0.005 | 0.005 |
| 12 | Alphaprodine | 25.0 | 25.0 |
| 13 | 3‑(2‑Aminopropyl)indole (alpha‑methyltryptamine (AMT)) | 2.0 | 2.0 |
| 14 | 5‑(2‑Aminopropyl)‑2,3‑dihydro‑1h‑indene (5‑APDI) | 0.75 | 0.5 |
| 15 | Amphecloral | 2.0 | 2.0 |
| 16 | Amphetamine | 0.75 | 2.0 |
| 17 | Anileridine | 25.0 | 25.0 |
| 18 | Barbiturates | 5.0 | 50.0 |
| 19 | Benzethidine | 10.0 | 10.0 |
| 20 | 1‑(Benzofuran‑6‑yl) propan‑2‑amine (6‑APB) | 0.75 | 0.5 |
| 21 | Benzoylecgonine | 2.0 | 2.0 |
| 22 | Benzylmorphine | 5.0 | 5.0 |
| 23 | Benzylpiperazine | 0.75 | 2.0 |
| 24 | Betacetylmethadol | 5.0 | 5.0 |
| 25 | beta‑Hydroxyfentanyl | 0.005 | 0.005 |
| 26 | beta‑Hydroxy‑3‑methylfentanyl | 0.005 | 0.005 |
| 27 | beta‑Keto‑N‑methyl‑3,4‑benzodioxyolylbutanamine (butylone) | 0.75 | 2.0 |
| 28 | Betameprodine | 5.0 | 5.0 |
| 29 | Betamethadol | 5.0 | 5.0 |
| 30 | Betaprodine | 5.0 | 5.0 |
| 31 | Bezitramide | 5.0 | 5.0 |
| 32 | 4‑Bromo‑2,5‑dimethoxyamphetamine | 0.5 | 0.5 |
| 33 | 2‑(4‑bromo‑2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl) methyl]ethanamine (25‑B‑NBOMe) | 0.002 | 0.002 |
| 34 | Bufotenine | 2.0 | 2.0 |
| 35 | Cannabinoids (other than a Cannabinoid of a kind that can be obtained from a plant that is not a Cannabis plant) | 2.0 | 2.0 |
| 36 | Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre) | 100.0 | 25,000.0 |
| 37 | Cannabis resin | 50.0 | 20.0 |
| 38 | Cathinone | 0.75 | 2.0 |
| 39 | 1‑(4‑Chloro‑2,5‑dimethoxyphenyl)‑2‑ethenamine (2C‑C) | 0.5 | 0.5 |
| 40 | 2‑(4‑chloro‑2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl) methyl]ethanamine (25‑C‑NBOMe) | 0.002 | 0.002 |
| 41 | Chlorphentermine | 2.0 | 2.0 |
| 42 | Clonitazene | 5.0 | 5.0 |
| 43 | Cocaine | 2.0 | 2.0 |
| 44 | Codeine | 10.0 | 10.0 |
| 45 | Codeine‑N‑oxide | 10.0 | 10.0 |
| 46 | Codoxime | 10.0 | 10.0 |
| 47 | Desomorphine | 2.0 | 2.0 |
| 48 | Dexamphetamine | 2.0 | 2.0 |
| 49 | Dextromoramide | 2.0 | 2.0 |
| 50 | Diampromide | 5.0 | 5.0 |
| 51 | Diethylpropion (N, N‑Diethylcathinone) | 5.0 | 5.0 |
| 52 | Diethylthiambutene | 5.0 | 5.0 |
| 53 | N,N‑Diethyltryptamine | 2.0 | 2.0 |
| 54 | Difenoxin | 2.0 | 2.0 |
| 55 | Dihydrocodeine | 10.0 | 10.0 |
| 56 | Dihydromorphine | 10.0 | 10.0 |
| 57 | Dimenoxadol | 10.0 | 10.0 |
| 58 | Dimepheptanol | 10.0 | 10.0 |
| 59 | 2,5‑Dimethoxy‑4‑bromophenethylamine (2C‑B) | 0.5 | 0.5 |
| 60 | 2,5‑Dimethoxy‑4‑(n)‑butylthiophenethylamine (2C‑T‑9) | 0.5 | 0.5 |
| 61 | 2,5‑Dimethoxy‑4‑ethylphenethylamine (2C‑E) | 0.5 | 0.5 |
| 62 | 2,5‑Dimethoxy‑4‑ethylthiophenethylamine (2C‑T‑2) | 0.5 | 0.5 |
| 63 | 2,5‑Dimethoxy‑4‑iodophenethylamine (2C‑I) | 0.5 | 0.5 |
| 64 | 2,5‑Dimethoxy‑4‑(β‑isobutylthio)phenethylamine (2C‑T‑17) | 0.5 | 0.5 |
| 65 | 2,5‑Dimethoxy‑4‑isopropylthiophenethylamine (2C‑T‑4) | 0.5 | 0.5 |
| 66 | 2,5‑Dimethoxy‑4‑(β‑methoxyethylthio)phenethylamine (2C‑T‑13) | 0.5 | 0.5 |
| 67 | 2,5‑Dimethoxy‑4‑methylamphetamine (STP, DOM) | 0.75 | 2.0 |
| 68 | 2,5‑Dimethoxy‑4‑methylphenethylamine (2C‑D) | 0.5 | 0.5 |
| 69 | 2,5‑Dimethoxy‑4‑nitrophenethylamine (2C‑N) | 0.5 | 0.5 |
| 70 | 2,5‑Dimethoxy‑4‑(n)‑propylphenethylamine (2C‑P) | 0.5 | 0.5 |
| 71 | 2,5‑Dimethoxy‑4‑n‑propylthiophenethylamine (2C‑T‑7) | 0.5 | 0.5 |
| 72 | 2‑(2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl)methyl] ethanamine (25‑H‑NBOMe) | 0.002 | 0.002 |
| 73 | 1‑Dimethylamino‑1,2‑diphenylethane | 5.0 | 5.0 |
| 74 | 1,1‑Dimethylheptyl‑11‑hydroxytetrahydrocannabinol (HU‑210) | 5.0 | 2.0 |
| 75 | Dimethylthiambutene | 20.0 | 20.0 |
| 76 | N,N‑Dimethyltryptamine | 2.0 | 2.0 |
| 77 | Dioxaphetyl butyrate | 2.0 | 2.0 |
| 78 | Diphenoxylate | 2.0 | 2.0 |
| 79 | Dipipanone | 10.0 | 10.0 |
| 80 | Drotebanol | 2.0 | 2.0 |
| 81 | Ecgonine | 10.0 | 10.0 |
| 82 | Ethchlorvynol | 50.0 | 50.0 |
| 83 | Ethinamate | 50.0 | 50.0 |
| 84 | Ethylmethylthiambutene | 10.0 | 10.0 |
| 85 | Ethylmorphine | 2.0 | 2.0 |
| 86 | Etonitazene | 5.0 | 5.0 |
| 87 | Etorphine | 5.0 | 5.0 |
| 88 | Etoxeridine | 5.0 | 5.0 |
| 89 | Fentanyl | 0.005 | 0.005 |
| 90 | 4‑Fluoro‑2,5‑dimethoxyphenethylamine (2C‑F) | 0.5 | 0.5 |
| 91 | 4‑(2‑Fluoroethylthio)‑2,5‑dimethoxyphenethylamine (2C‑T‑21) | 0.5 | 0.5 |
| 92 | 1‑(5‑fluoropentyl)‑3‑(2‑iodobenzyl)indole (AM‑694) | 5.0 | 2.0 |
| 93 | Furethidine | 1.0 | 1.0 |
| 94 | Gammabutyrolactone (GBL) | 1.0 | 2.0 |
| 95 | Glutethimide | 50.0 | 50.0 |
| 96 | Harmaline | 5.0 | 2.0 |
| 97 | Harmine | 5.0 | 2.0 |
| 98 | Heroin (diacetylmorphine) | 1.5 | 2.0 |
| 99 | Hydrocodone | 2.0 | 2.0 |
| 100 | Hydromorphinol | 2.0 | 2.0 |
| 101 | Hydromorphone | 2.0 | 2.0 |
| 102 | Hydroxyamphetamine | 2.0 | 2.0 |
| 103 | 4‑Hydroxybutanoic acid (GHB) | 1.0 | 2.0 |
| 104 | 2‑[(1R,3S)‑3‑hydroxycyclohexyl]‑5‑ (2‑methyloctan‑2‑yl)phenol (CP 47,497) | 5.0 | 2.0 |
| 105 | 2‑[(1R,3S)‑3‑hydroxycyclohexyl]‑5‑ (2‑methylnonan‑2‑yl)phenol (CP 47,497‑C8) | 5.0 | 2.0 |
| 106 | Hydroxypethidine | 5.0 | 5.0 |
| 107 | 2‑(4‑iodo‑2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl) methyl]ethanamine (25‑I‑NBOMe) | 0.002 | 0.002 |
| 108 | Isomethadone | 2.0 | 2.0 |
| 109 | 4‑Isopropoxy‑2,5‑dimethoxyphenethylamine (2C‑O‑4) | 0.5 | 0.5 |
| 110 | Ketamine | 1.0 | 3.0 |
| 111 | Ketobemidone | 2.0 | 2.0 |
| 112 | Levomethorphan | 2.0 | 2.0 |
| 113 | Levophenacylmorphan | 2.0 | 2.0 |
| 114 | Levorphanol, but not including dextrorphan | 1.0 | 1.0 |
| 115 | Lysergamide | 0.01 | 0.1 |
| 116 | Lysergide (LSD) | 0.002 | 0.002 |
| 117 | Meprobamate | 50.0 | 50.0 |
| 118 | Mescaline | 7.5 | 7.5 |
| 119 | Metazocine | 7.0 | 7.0 |
| 120 | Methadone | 2.0 | 2.0 |
| 121 | Methamphetamine | 0.75 | 2.0 |
| 122 | Methaqualone | 5.0 | 50.0 |
| 123 | Methcathinone | 0.75 | 2.0 |
| 124 | Methorphan, but not including dextromethorphan | 2.0 | 2.0 |
| 125 | 5‑Methoxy‑alpha‑methyltryptamine (5‑MeO‑AMT) | 2.0 | 2.0 |
| 126 | 4‑Methoxyamphetamine | 0.75 | 2.0 |
| 127 | 5‑Methoxy‑N,N‑diisopropyltryptamine (5‑MeO‑DiPT) | 2.0 | 2.0 |
| 128 | 4‑Methoxymethamphetamine | 0.75 | 2.0 |
| 129 | 2‑(2‑Methoxyphenyl)‑1‑(1‑pentylindol‑3‑yl)ethanone (JWH‑250) | 5.0 | 2.0 |
| 130 | 4‑Methylamphetamine | 0.75 | 2.0 |
| 131 | Methyldesorphine | 2.0 | 2.0 |
| 132 | Methyldihydromorphine | 2.0 | 2.0 |
| 133 | 3,4‑Methylenedioxyamphetamine (MDA) | 0.75 | 0.5 |
| 134 | 3,4‑Methylenedioxymethamphetamine (MDMA) | 0.5 | 0.5 |
| 135 | 3,4‑Methylenedioxypyrovalerone (MDPV) | 0.75 | 2.0 |
| 136 | 3‑Methylfentanyl | 0.005 | 0.005 |
| 137 | 4‑Methylmethamphetamine | 0.75 | 2.0 |
| 138 | 4‑Methylmethcathinone (4‑MMC) | 0.75 | 2.0 |
| 139 | Methylphenidate | 2.0 | 2.0 |
| 140 | 1‑Methyl‑4‑phenyl‑4‑propionoxypiperidine (MPPP) | 2.0 | 2.0 |
| 141 | 4‑Methylthio‑2,5‑dimethoxyphenethylamine (2C‑T) | 0.5 | 0.5 |
| 142 | 4‑Methylthioamphetamine (4‑MTA) | 0.75 | 2.0 |
| 143 | 4‑Methylthiobutylamphetamine (4‑MTBA) | 0.75 | 2.0 |
| 144 | 4‑Methylthiodimethamphetamine (4‑MTDMA) | 0.75 | 2.0 |
| 145 | 4‑Methylthioethylamphetamine (4‑MTEA) | 0.75 | 2.0 |
| 146 | 3‑Methylthiofentanyl | 0.005 | 0.005 |
| 147 | 4‑Methylthiomethamphetamine (4‑MTMA) | 0.75 | 2.0 |
| 148 | 4‑Methylthiopropylamphetamine (4‑MTPA) | 0.75 | 2.0 |
| 149 | Methyprylon | 50.0 | 50.0 |
| 150 | Metopon | 2.0 | 2.0 |
| 151 | Monoacetylmorphines | 2.0 | 2.0 |
| 152 | Moramide | 2.0 | 2.0 |
| 153 | Morphan, but not including dextrorphan | 2.0 | 2.0 |
| 154 | Morpheridine | 2.0 | 2.0 |
| 155 | Morphine | 1.5 | 2.0 |
| 156 | Morphine‑N‑oxide | 2.0 | 2.0 |
| 157 | (1‑(2‑Morpholin‑4‑ylethyl)indol‑3‑yl)‑napthalen‑1‑ ylmethanone (JWH‑200) | 5.0 | 2.0 |
| 158 | Myrophine | 20.0 | 20.0 |
| 159 | Napthalen‑1‑yl‑(1‑butylindol‑3‑yl)methanone (JWH‑073) | 5.0 | 2.0 |
| 160 | Nicocodine | 2.0 | 2.0 |
| 161 | Nicodicodine | 2.0 | 2.0 |
| 162 | Nicomorphine | 2.0 | 2.0 |
| 163 | Noracymethadol | 2.0 | 2.0 |
| 164 | Norcodeine | 2.0 | 2.0 |
| 165 | Norlevorphanol | 2.0 | 2.0 |
| 166 | Normethadone | 5.0 | 5.0 |
| 167 | Normorphine | 20.0 | 20.0 |
| 168 | Norpipanone | 10.0 | 10.0 |
| 169 | Opium | 20.0 | 20.0 |
| 170 | Oripavine | 2.0 | 2.0 |
| 171 | Oxycodone | 5.0 | 5.0 |
| 172 | Oxymorphone | 2.0 | 2.0 |
| 173 | para‑Fluorofentanyl | 0.005 | 0.005 |
| 174 | Pentazocine | 20.0 | 20.0 |
| 175 | 1‑Pentyl‑3‑(1‑napthoyl)indol (JWH‑018) | 5.0 | 2.0 |
| 176 | 1‑Pentyl‑3‑(4‑methyl‑1‑napthoyl)indole (JWH‑122) | 5.0 | 2.0 |
| 177 | Pethidine | 10.0 | 10.0 |
| 178 | Phenadoxone | 10.0 | 10.0 |
| 179 | Phenampromide | 10.0 | 10.0 |
| 180 | Phenazocine | 1.0 | 1.0 |
| 181 | Phencyclidine | 2.0 | 2.0 |
| 182 | Phendimetrazine | 5.0 | 5.0 |
| 183 | Phenmetrazine | 5.0 | 5.0 |
| 184 | Phenomorphan | 5.0 | 5.0 |
| 185 | Phenoperidine | 1.0 | 1.0 |
| 186 | Phentermine | 5.0 | 5.0 |
| 187 | 1‑Phenylethyl‑4‑phenyl‑4‑acetoxypiperidine (PEPAP) | 2.0 | 2.0 |
| 188 | Pholcodine | 5.0 | 5.0 |
| 189 | Piminodine | 10.0 | 10.0 |
| 190 | Pipradrol | 1.0 | 1.0 |
| 191 | Piritramide | 1.0 | 1.0 |
| 192 | Proheptazine | 1.0 | 1.0 |
| 193 | Properidine | 25.0 | 25.0 |
| 194 | Propiram | 10.0 | 10.0 |
| 195 | Psilocine | 0.1 | 0.1 |
| 196 | Psilocybine | 0.1 | 0.1 |
| 197 | Pyrovalerone | 0.75 | 2.0 |
| 198 | Tetrahydrocannabinols (THC) | 5.0 | 2.0 |
| 199 | Thebacon | 2.0 | 2.0 |
| 200 | Thebaine | 2.0 | 2.0 |
| 201 | Thiofentanyl | 0.005 | 0.005 |
| 202 | Trimeperidine | 10.0 | 10.0 |
| 203 | 2,3,4‑Trimethoxyamphetamine | 0.75 | 2.0 |
| 204 | 2,3,5‑Trimethoxyamphetamine | 0.75 | 2.0 |
| 205 | 2,3,6‑Trimethoxyamphetamine | 0.75 | 2.0 |
| 206 | 2,4,5‑Trimethoxyamphetamine | 0.75 | 2.0 |
| 207 | 2,4,6‑Trimethoxyamphetamine | 0.75 | 2.0 |
| 208 | 3,4,5‑Trimethoxyamphetamine | 0.75 | 2.0 |
| 209 | 2,4,5‑Trimethoxyphenethylamine (2C‑O) | 0.5 | 0.5 |
Endnotes
Endnote 1—About the endnotes
The endnotes provide information about this compilation and the compiled law.
The following endnotes are included in every compilation:
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history
Abbreviation key—Endnote 2
The abbreviation key sets out abbreviations that may be used in the endnotes.
Legislation history and amendment history—Endnotes 3 and 4
Amending laws are annotated in the legislation history and amendment history.
The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.
The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.
Editorial changes
The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.
If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.
Misdescribed amendments
A misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.
If a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not incorp)” is added to the details of the amendment included in the amendment history.
Endnote 2—Abbreviation key
| ad = added or inserted | o = order(s) |
| am = amended | Ord = Ordinance |
| amdt = amendment | orig = original |
| c = clause(s) | par = paragraph(s)/subparagraph(s) |
| C[x] = Compilation No. x | /sub‑subparagraph(s) |
| Ch = Chapter(s) | pres = present |
| def = definition(s) | prev = previous |
| Dict = Dictionary | (prev…) = previously |
| disallowed = disallowed by Parliament | Pt = Part(s) |
| Div = Division(s) | r = regulation(s)/rule(s) |
| ed = editorial change | reloc = relocated |
| exp = expires/expired or ceases/ceased to have | renum = renumbered |
| effect | rep = repealed |
| F = Federal Register of Legislation | rs = repealed and substituted |
| gaz = gazette | s = section(s)/subsection(s) |
| LA = Legislation Act 2003 | Sch = Schedule(s) |
| LIA = Legislative Instruments Act 2003 | Sdiv = Subdivision(s) |
| (md) = misdescribed amendment can be given | SLI = Select Legislative Instrument |
| effect | SR = Statutory Rules |
| (md not incorp) = misdescribed amendment | Sub‑Ch = Sub‑Chapter(s) |
| cannot be given effect | SubPt = Subpart(s) |
| mod = modified/modification | underlining = whole or part not |
| No. = Number(s) | commenced or to be commenced |
Endnote 3—Legislation history
| Name | Registration | Commencement | Application, saving and transitional provisions |
| Criminal Code Regulations 2019 | 8 Apr 2019 (F2019L00561) | 9 Apr 2019 (s 2(1) item 1) | |
| Criminal Code and Customs Legislation Amendment (Precursors and Drugs) Regulations 2020 | 10 Aug 2020 (F2020L01003) | Sch 1 (items 1–12): 12 Aug 2020 (s 2(1) item 1) | — |
| Counter‑Terrorism Legislation Amendment (High Risk Terrorist Offenders) Regulations 2021 | 20 Dec 2021 (F2021L01842) | Sch 1 (item 1): 21 Dec 2021 (s 2(1) item 1) | — |
Endnote 4—Amendment history
| Provision affected | How affected |
| Part 1 | |
| s 2............................................. | rep LA s 48D |
| Part 2 | |
| Division 3 | |
| s 10........................................... | am F2021L01842 |
| Part 3 | |
| Division 1 | |
| s 13........................................... | am F2020L01003 |
| s 16........................................... | am F2020L01003 |
0
0
0